169 related articles for article (PubMed ID: 17875892)
21. The role of Shp2 (PTPN11) in cancer.
Mohi MG; Neel BG
Curr Opin Genet Dev; 2007 Feb; 17(1):23-30. PubMed ID: 17227708
[TBL] [Abstract][Full Text] [Related]
22. Multiple granular cell tumors are an associated feature of LEOPARD syndrome caused by mutation in PTPN11.
Schrader KA; Nelson TN; De Luca A; Huntsman DG; McGillivray BC
Clin Genet; 2009 Feb; 75(2):185-9. PubMed ID: 19054014
[TBL] [Abstract][Full Text] [Related]
23. PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia.
Yamamoto T; Isomura M; Xu Y; Liang J; Yagasaki H; Kamachi Y; Kudo K; Kiyoi H; Naoe T; Kojma S
Leuk Res; 2006 Sep; 30(9):1085-9. PubMed ID: 16533526
[TBL] [Abstract][Full Text] [Related]
24. PTPN11 gene mutations: linking the Gln510Glu mutation to the "LEOPARD syndrome phenotype".
Digilio MC; Sarkozy A; Pacileo G; Limongelli G; Marino B; Dallapiccola B
Eur J Pediatr; 2006 Nov; 165(11):803-5. PubMed ID: 16733669
[TBL] [Abstract][Full Text] [Related]
25. Mutation screening of the PTPN11 gene in hypertrophic cardiomyopathy.
Limongelli G; Hawkes L; Calabro R; McKenna WJ; Syrris P
Eur J Med Genet; 2006; 49(5):426-30. PubMed ID: 16488201
[TBL] [Abstract][Full Text] [Related]
26. Mutations of PTPN11 are rare in adult myeloid malignancies.
Hugues L; Cavé H; Philippe N; Pereira S; Fenaux P; Preudhomme C
Haematologica; 2005 Jun; 90(6):853-4. PubMed ID: 15951301
[TBL] [Abstract][Full Text] [Related]
27. Severe aortic valvar stenosis in familial Noonan syndrome with mutation of the PTPN11 gene.
Abadir S; Edouard T; Julia S
Cardiol Young; 2007 Feb; 17(1):95-7. PubMed ID: 17184563
[TBL] [Abstract][Full Text] [Related]
28. PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.
Loh ML; Reynolds MG; Vattikuti S; Gerbing RB; Alonzo TA; Carlson E; Cheng JW; Lee CM; Lange BJ; Meshinchi S;
Leukemia; 2004 Nov; 18(11):1831-4. PubMed ID: 15385933
[TBL] [Abstract][Full Text] [Related]
29. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
Qin C; Wavreille AS; Pei D
Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
[TBL] [Abstract][Full Text] [Related]
30. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
31. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene.
Sznajer Y; Keren B; Baumann C; Pereira S; Alberti C; Elion J; Cavé H; Verloes A
Pediatrics; 2007 Jun; 119(6):e1325-31. PubMed ID: 17515436
[TBL] [Abstract][Full Text] [Related]
32. IMAGE CARDIO MED. A patient with LEOPARD syndrome and PTPN11 mutation.
Lehmann LH; Schaeufele T; Buss SJ; Balanova M; Hartschuh W; Ehlermann P; Katus HA
Circulation; 2009 Mar; 119(9):1328-9. PubMed ID: 19273734
[No Abstract] [Full Text] [Related]
33. Noonan syndrome with leukaemoid reaction and overproduction of catecholamines: a case report.
Kondoh T; Ishii E; Aoki Y; Shimizu T; Zaitsu M; Matsubara Y; Moriuchi H
Eur J Pediatr; 2003 Jul; 162(7-8):548-549. PubMed ID: 12739139
[No Abstract] [Full Text] [Related]
34. The tyrosine phosphatase Shp2 (PTPN11) in cancer.
Chan G; Kalaitzidis D; Neel BG
Cancer Metastasis Rev; 2008 Jun; 27(2):179-92. PubMed ID: 18286234
[TBL] [Abstract][Full Text] [Related]
35. Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism.
Jafarov T; Ferimazova N; Reichenberger E
Clin Genet; 2005 Aug; 68(2):190-1. PubMed ID: 15996221
[No Abstract] [Full Text] [Related]
36. Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome.
Limongelli G; Pacileo G; Marino B; Digilio MC; Sarkozy A; Elliott P; Versacci P; Calabro P; De Zorzi A; Di Salvo G; Syrris P; Patton M; McKenna WJ; Dallapiccola B; Calabro R
Am J Cardiol; 2007 Aug; 100(4):736-41. PubMed ID: 17697839
[TBL] [Abstract][Full Text] [Related]
37. LEOPARD syndrome: clinical diagnosis in the first year of life.
Digilio MC; Sarkozy A; de Zorzi A; Pacileo G; Limongelli G; Mingarelli R; Calabrò R; Marino B; Dallapiccola B
Am J Med Genet A; 2006 Apr; 140(7):740-6. PubMed ID: 16523510
[TBL] [Abstract][Full Text] [Related]
38. Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1.
Hanna N; Montagner A; Lee WH; Miteva M; Vidal M; Vidaud M; Parfait B; Raynal P
FEBS Lett; 2006 May; 580(10):2477-82. PubMed ID: 16638574
[TBL] [Abstract][Full Text] [Related]
39. Mild variable Noonan syndrome in a family with a novel PTPN11 mutation.
Zenker M; Voss E; Reis A
Eur J Med Genet; 2007; 50(1):43-7. PubMed ID: 17052965
[TBL] [Abstract][Full Text] [Related]
40. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]